Tg Therapeutics: MACD Death Cross and KDJ Death Cross Triggered on 15min Chart

Thursday, Sep 4, 2025 10:04 am ET1min read

According to the technical indicators on Tg Therapeutics' 15-minute chart, a MACD Death Cross and KDJ Death Cross occurred on September 4, 2023 at 10:00. This suggests that the stock price may continue to decline, and the momentum is shifting towards the downside, potentially leading to further decreases.

Tg Therapeutics (TGTX), a biopharmaceutical innovator advancing therapies for B-cell malignancies and autoimmune disorders, has recently experienced significant technical indicators that suggest a potential downturn in its stock price. According to the 15-minute chart, a MACD Death Cross and KDJ Death Cross occurred on September 4, 2023, at 10:00. These indicators typically signal a shift in momentum towards the downside, potentially leading to further decreases in the stock price [1].

The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, indicating a bearish trend. The KDJ (Kaufman Adaptive Moving Average) Death Cross, similarly, suggests a decline in momentum. Both indicators are widely used by traders to identify potential reversals in stock price trends.

These technical signals come at a time when Tg Therapeutics has been reporting strong financial results and making significant progress in its clinical pipeline. For instance, in the second quarter of 2025, the company reported total revenue of $141.1 million, with BRIUMVI U.S. net revenue reaching $138.8 million, a 91% year-over-year increase [2]. Despite these positive developments, the technical indicators suggest a potential downward pressure on the stock price.

Investors should remain vigilant and monitor the stock's performance closely, as the technical signals could indicate a trend reversal. It is essential to consider both fundamental and technical analysis when making investment decisions.

References:
[1] https://www.stocktitan.net/news/TGTX/
[2] https://www.stocktitan.net/news/TGTX/

Comments



Add a public comment...
No comments

No comments yet